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vascular (CV) events (n=32 CV in 24 pts; 1.3 CV/pt), including death (n=4 pts), urgent 
PTCA (n=9 pts) or bypass grafting (n=7 pts), re-AMI (n=5 pts) and recurrent angina >2 
CCS (n=7 pts). Our AMI population (n=40 pts) was divided into 2 groups according to the 
occurence of major CV events at 6 months, CV- @=I6 pts) and CV+ (n=24 pts). Between 
day l-10 post AMI, the CV+ group registered significant differences concerning the MCM 
mean values of CD1 1 b (194*35 cells/mm~, CD43 (44.9220 cellsimm3) and CD1 1 b/43 
(6.7t2.2) when compared with the CV- group values of CD11 b (157.5+28 cells/mm3; 
p=O.Oi), CD43 (44.8*17 cells/mm3; p=ns) and CD11 b/43 (4.4i1.9: p=O.Ol). MCM evalu- 
ation early after the onset of acute ischsmia reflect the degree of cell inflammation and 
recruitment associated with plaque instability and myocardial infarction, revealing a clear 
prognostic value in the long term follow-up of this ischemic coronary pathology. 
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Background: Elevated serum troponin-I (Tn-I) and C-reactive protein (CRP) levels both 
predict an increased risk of mortality in patients with acute coronary syndromes (ACS). 
However, their independent and joint predictive value is less well defined, and previous 
studies have not differentiated risk based on gender. The objective of this study was to 
determine the independent and joint prediitive value of Tn-I and CRP and the effect of 
gender on the prediction of death or myocardial infarction (D/Ml) in ACS patients. 
Methods: Patients (294 females, 541 males) admitted to LDS Hospital for angina1 symp- 
toms and who underwent angiography were studied. Serial Tn.1 levels (Abbott) were 
measured during the first 24 hours, and baseline CRP levels (Abbott) were assessed at 
angiography. Results were diwded into quartiles and also categorized by recursive parti- 
tioning. Patients were followed for a mean of 2.3*1 .l years for D/Ml. Analysis used Cox 
regression. 
Results: At entry, average age was 63*13 years; 38% had MI; 68% had severe coronary 
artery disease (CAD) (270% stenosis), 10% had moderate CAD (lo-69% stenosis). and 
22% had no CAD. D/MI occurred in 17.4% of males and 22.1% of females (p=O.lO). In 
Cox regression, both CRP (p=O.O03) and Tn-I (p=O.O2) were independently predictive of 
D/MI. An interaction of Tn-I with female gender, but not CRP with gender, was suggested 
by the quartile analyses, and recursive partitioning was used to categorize Tn-I into cl.2 
mg/dL (n=392), 1.21-43.35 mg/dL (n=288), and >43.35 mg/dL (n=l55) strata. Further 
modeling showed that Tn.1 >43.35 conferred differential risk to females (hazard ratio 
[HR]=4.6, 95% Cl= 2.5-8.7) compared to males (HR=1.6, 95% Cl=O.95-2.8) (adjusted p- 
interaction= 0.03). Among all patients, the adjusted HR due to CRP was 1.2, 1.6, 1.7 for 
the second (p=O.22), third (p=O.O8), and fourth quartiles (p=O.o48). respectively. 
Conclusions: Both Tn-I and CRP independently predict longitudinal risk of D/MI among 
patients admitted with ACS regardless of gender. However, the risk of O/MI is amplified 
in females with high Tn.1 (>43 mg/dL) on presentation, suggesting that aggressive man- 
agement strategies for high-risk ACS should particularly focus on women. 
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Background: The infarct scar is living tissue. It includes a neovasculature formed by 
angiogenic (capillary sprouting) and vasculogenic (bone marrow-derived endothelial pro- 
genitor cells) components. Current interest focuses on regenerating functional myocar- 
dial tissue at the infarct site as a means of preventing heart failure. Rebuilt myocardium, 
whether derived from endogenous or exogenous sources, must include a vascular nst- 
work able to nourish cardiomyocytes under diverse metabolic demands. 
Methods: We have adapted a series of techniques used to characterize tumor vascular- 
ity, perfusion, and levels of hypoxia, to quantify the components and functionality (ability 
to deliver oxygen) of the scar vascular network at l-4 wks following myocardial infarction 
(MI) in rats. Fluorescent staining with DiOC7(3) and PECAM-l/CD31 was used to 
respectively visualize perfused and non-perfused vessels and immunohistochemlcal 
staining with EF5/Cy3 to quantitate tissue hypoxia in infarcted tissue following left coro- 
nary artery ligation. Non-infarcted hearts sewed as controls. 
Results: Results to date indicate the number of perfused vessels at the infarct site 
declines during wks 1 and 2 post-MI and is accompanied by a progressive increase in 
both the distance to the nearest perfused blood vessel and the level of tissue hypoxia. At 
wks 3 & 4 post-Ml, the number of perfused vessels at the Infarct site is significantly 
(~~0.05) increased and is accompanied by a progressive decrease in the distance to the 
nearest perfused vessel and level of tissue hypoxia.Conclusion: Despite this favorable 
growth of the neovasculature, its dimensions and capacity to deliver oxygen are consid- 
erably less (-70%) than that of the normal coronary circulation suggesting a need to 
invoke a greater growth of angiogenic and vasculogenic components of the scar neovas- 
culature during the early post-Ml period. 
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Correlation With C-Reactive Proteln 
Jean-Luc Bueb, Daniela M. Zardini, Eric J. Tschirhart, Malou Gloesener, Georges Gilson, 
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Background: Metalloproteinases (MMPs) appear to play an important role in the devel- 
opment of plaque rupture and acute myocardial infarction (AMI). Small series have 
shown that peripheral levels of MMP-2 and MMP-9 are elevated in patients with acute 
coronary syndrome. The aim of this sudy was to determine the relationship between 
MMP-2, MMP-9 and high-sensitivity C-reactive protein (hs-CRP), a classical marker of 
inflammation, in patients with AMI. Methods We measured MMP-2, MMP-9. and hs- 
CRP in peripheral blood samples from 397 consecutive patients undergoing coronary 
angiography. The activities of MMP-2 and MMP-9 were determmed using zymography 
and densitometry analysis (area under the curve). Levels of hs-CRP were measured with 
sandwich enzyme immunoassay. Results: Of 397 consecutive patients, 49 had AMI and 
the remaining had unstable angina, stable angina, cardiomyopathy or valvular disease. 
MMP-2 activity was not elevated in patients with AMI (455*24 vs. 495+10 pixel$). How- 
ever, MMP-9 activity was 2.4.fold increased in patients with AMI (206i76 vs. 85*3 
pixels’. pcO.0005). and was highest during the first 24 hours post AMI (522+270 vs. 85i3 
pixels’, p<O.OOOOl). MMP-9 activity appeared to be correlated with the severity of AMI. 
peak actrvitfes being observed in 2 patients with AMI and cardiac arrest (1310 and 3507 
pixels2). Levels of hs-CRP were 3.9.fold increased in patients with AMI (3.liO.6 vs. 
0.8iO.l mgldl, p~O.00001) but did not correlate with the rise in MMP-9 activity. Conclu- 
sions: Levels of MMP-9 and hs-CRP are elevated in patients with AMI. There is no cor- 
relation between both biomarkers. Whether MMP-9 is a more specific marker of cardiac 
inflammation than hs-CRP remains to be determined. 
1194-l 00 Short-Term Atorvastatin Pretreatment Reduces 
Myocardial Infarct Size in Normocholesterolemic Rats 
Yochai Birnbaum, Taras Ashitkov, Barry F. Uretsky, Scott Ballinger, Massoud Motamedi, 
University of Texas Medical Branch, Galveston, TX 
Background: Previous studies have suggested that HMG-CoA reductase inhibitors 
(statins) attenuate ischemla-reperfusion injury. We assessed whether shoe-term treat- 
ment with atorvastatin reduces myocardial infarct size. Methods and Results: We 
treated rats with atorvastatin (80 (n=l l), 10 (n=6), or 2 (n=8) mgikg) or water (n=ll) 
administered once daily for 3 d and induced myocardial infarction by ligation of a coro- 
nary artery for 30 mln followed by 3 h of reperlusion. lschemic area at risk was assessed 
with blue dye and infarct size by triphenyltetrazolium chloride. Infarct size was expressed 
as a percentage of the area at risk. Area at risk was comparable among group. In con- 
trast, infarct size, expressed as a percentage of the area at risk was significantly smaller 
in the atorvastatin 80 and 10 mglkg/d groups. In contrast, infarct size in the atorvastatin 2 
mg/kg/d was not statistically significant different from the control group. Conclusions: 
Short-term (3 days) atorvastatin significantly reduces the extent of myocardial necrosis 
after acute ischemitireperfusion injury 
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Monocyie cell membrane markers (MCM) are membrane proteins, ligands of cell adhe- 
sion molecules such as ICAM, VICAM and IL, associated with coronary artery plaque 
instability as a response to an acute ischemic process. MCM corresponds to cluster of 
differentiation (CD) used as quantitative indices of the activity of the inflammatory cell 
process and plaque instability that characteryzes acute coronary syndromes and myo- 
cardial infarction (AMI). The aim of this study was to assess the prognostic implications 
of MCM (CDllb and CD43) evaluahon I” early days post AMI. Blood samples were 
colected in EDTA at CCU <IO days post first AMI diagnosis and admission. After a selec- 
tive MCM process, flow citometty was applied to assess the concentration of MCM/mm3 
on the basis of 1 count 1 cell. Maximal and mean individual values (cells/mm3) and pha- 
SIC variation of CD1 1 b, CD43 and its ratio (CD1 1 b/43) were determined by flow cytome- 
try after specific monoclonal Ab targettrng, controled chamber flow conditions and laser 
detection. Other variables were evaluated, such as the maximal, mean values and pha- 
sic variation of C-reactive protein, total CK, CK-MB, myoglobin, troponin I and fibrinogen. 
Our AMI patients were analysed at 6 months in terms of the occurence of major cardio- 
